An interactive map about institutional investors and their engagement in the stock market
Equity Distribution for BIOMARIN PHARMACEUTICAL Inc
| Ticker | BMRN |
| FIGI | BBG000CZWZ05 |
| CUSIP | 09061G101 |
| Sector | Healthcare |
| Equity Type | Common Stock |
| No. Companies Holding this Equity | 532 / 7.6% |
| Percentage held by institutional investors | 96.6% |
About
BioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California. It has offices and facilities in the United States, South America, Asia, and Europe. BioMarin's core business and research is in enzyme replacement therapies (ERTs). BioMarin was the first company to provide therapeutics for mucopolysaccharidosis type I (MPS I), by manufacturing laronidase (Aldurazyme, commercialized by Genzyme Corporation). Wikipedia